サマリー

プロトンポンプ阻害薬（PPI）は、胃酸の分泌を長時間にわたって抑制することを主作用とする薬物である。
市場分析および洞察。処方用プロトンポンプ阻害剤の世界市場
COVID-19の流行により、世界の処方用プロトンポンプ阻害剤の市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR%で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年に処方用プロトンポンプ阻害剤世界市場の％を占めたランソプラゾールは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、病院分野は、この予測期間を通じて、年平均成長率（%）に変更されています。

2021年の中国処方型プロトンポンプ阻害剤の市場規模は百万米ドル、米国と欧州処方型プロトンポンプ阻害剤はそれぞれ百万米ドル、百万米ドルとなっています。2021年の米国の割合は％、中国と欧州はそれぞれ％と％であり、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGR％で推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのPPI（プロトンポンプ阻害剤）市場については、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
処方用プロトンポンプ阻害剤の世界の主要メーカーには、AstraZeneca、Cadila Pharmaceuticals、Eisai、Eli Lilly、Janssen、Pfizer、Santarus、Wyethなどが含まれます。2021年、世界の上位5社は売上高で約 %のシェアを持っています。

世界の処方用プロトンポンプ阻害剤の範囲とセグメント
処方箋型プロトンポンプ阻害剤市場は、タイプ別および用途別に分類されます。世界の処方型プロトンポンプ阻害剤市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
ランソプラゾール
パントプラゾール
ラベプラゾール
その他
用途別セグメント
病院
研究室
その他

会社別
アストラゼネカ
カディラ・ファーマシューティカルズ
エーザイ
イーライ・リリー
ヤンセン
ファイザー
サンタラス社
ワイス

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Prescription Proton Pump Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Proton Pump Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lansoprazole
1.2.3 Pantoprazole
1.2.4 Rabeprazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prescription Proton Pump Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prescription Proton Pump Inhibitor Sales Estimates and Forecasts 2017-2028
2.2 Global Prescription Proton Pump Inhibitor Revenue Estimates and Forecasts 2017-2028
2.3 Global Prescription Proton Pump Inhibitor Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prescription Proton Pump Inhibitor Sales by Region
2.4.1 Global Prescription Proton Pump Inhibitor Sales by Region (2017-2022)
2.4.2 Global Sales Prescription Proton Pump Inhibitor by Region (2023-2028)
2.5 Global Prescription Proton Pump Inhibitor Revenue by Region
2.5.1 Global Prescription Proton Pump Inhibitor Revenue by Region (2017-2022)
2.5.2 Global Prescription Proton Pump Inhibitor Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prescription Proton Pump Inhibitor Sales by Manufacturers
3.1.1 Global Top Prescription Proton Pump Inhibitor Manufacturers by Sales (2017-2022)
3.1.2 Global Prescription Proton Pump Inhibitor Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Proton Pump Inhibitor in 2021
3.2 Global Prescription Proton Pump Inhibitor Revenue by Manufacturers
3.2.1 Global Prescription Proton Pump Inhibitor Revenue by Manufacturers (2017-2022)
3.2.2 Global Prescription Proton Pump Inhibitor Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Proton Pump Inhibitor Revenue in 2021
3.3 Global Prescription Proton Pump Inhibitor Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prescription Proton Pump Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prescription Proton Pump Inhibitor Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Proton Pump Inhibitor Sales by Type
4.1.1 Global Prescription Proton Pump Inhibitor Historical Sales by Type (2017-2022)
4.1.2 Global Prescription Proton Pump Inhibitor Forecasted Sales by Type (2023-2028)
4.1.3 Global Prescription Proton Pump Inhibitor Sales Market Share by Type (2017-2028)
4.2 Global Prescription Proton Pump Inhibitor Revenue by Type
4.2.1 Global Prescription Proton Pump Inhibitor Historical Revenue by Type (2017-2022)
4.2.2 Global Prescription Proton Pump Inhibitor Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prescription Proton Pump Inhibitor Revenue Market Share by Type (2017-2028)
4.3 Global Prescription Proton Pump Inhibitor Price by Type
4.3.1 Global Prescription Proton Pump Inhibitor Price by Type (2017-2022)
4.3.2 Global Prescription Proton Pump Inhibitor Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prescription Proton Pump Inhibitor Sales by Application
5.1.1 Global Prescription Proton Pump Inhibitor Historical Sales by Application (2017-2022)
5.1.2 Global Prescription Proton Pump Inhibitor Forecasted Sales by Application (2023-2028)
5.1.3 Global Prescription Proton Pump Inhibitor Sales Market Share by Application (2017-2028)
5.2 Global Prescription Proton Pump Inhibitor Revenue by Application
5.2.1 Global Prescription Proton Pump Inhibitor Historical Revenue by Application (2017-2022)
5.2.2 Global Prescription Proton Pump Inhibitor Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prescription Proton Pump Inhibitor Revenue Market Share by Application (2017-2028)
5.3 Global Prescription Proton Pump Inhibitor Price by Application
5.3.1 Global Prescription Proton Pump Inhibitor Price by Application (2017-2022)
5.3.2 Global Prescription Proton Pump Inhibitor Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prescription Proton Pump Inhibitor Market Size by Type
6.1.1 North America Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
6.1.2 North America Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
6.2 North America Prescription Proton Pump Inhibitor Market Size by Application
6.2.1 North America Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
6.2.2 North America Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
6.3 North America Prescription Proton Pump Inhibitor Market Size by Country
6.3.1 North America Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
6.3.2 North America Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Prescription Proton Pump Inhibitor Market Size by Type
7.1.1 Europe Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
7.1.2 Europe Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
7.2 Europe Prescription Proton Pump Inhibitor Market Size by Application
7.2.1 Europe Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
7.2.2 Europe Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
7.3 Europe Prescription Proton Pump Inhibitor Market Size by Country
7.3.1 Europe Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
7.3.2 Europe Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Type
8.1.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
8.1.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
8.2 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Application
8.2.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
8.2.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
8.3 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Region
8.3.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Region (2017-2028)
8.3.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prescription Proton Pump Inhibitor Market Size by Type
9.1.1 Latin America Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
9.1.2 Latin America Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
9.2 Latin America Prescription Proton Pump Inhibitor Market Size by Application
9.2.1 Latin America Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
9.2.2 Latin America Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
9.3 Latin America Prescription Proton Pump Inhibitor Market Size by Country
9.3.1 Latin America Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
9.3.2 Latin America Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Type
10.1.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
10.2 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Application
10.2.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
10.3 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Country
10.3.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Corporation Information
11.2.2 Cadila Pharmaceuticals Overview
11.2.3 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cadila Pharmaceuticals Recent Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Overview
11.3.3 Eisai Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eisai Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eisai Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Janssen
11.5.1 Janssen Corporation Information
11.5.2 Janssen Overview
11.5.3 Janssen Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Janssen Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Santarus
11.7.1 Santarus Corporation Information
11.7.2 Santarus Overview
11.7.3 Santarus Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Santarus Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Santarus Recent Developments
11.8 Wyeth
11.8.1 Wyeth Corporation Information
11.8.2 Wyeth Overview
11.8.3 Wyeth Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wyeth Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wyeth Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Proton Pump Inhibitor Industry Chain Analysis
12.2 Prescription Proton Pump Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Proton Pump Inhibitor Production Mode & Process
12.4 Prescription Proton Pump Inhibitor Sales and Marketing
12.4.1 Prescription Proton Pump Inhibitor Sales Channels
12.4.2 Prescription Proton Pump Inhibitor Distributors
12.5 Prescription Proton Pump Inhibitor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prescription Proton Pump Inhibitor Industry Trends
13.2 Prescription Proton Pump Inhibitor Market Drivers
13.3 Prescription Proton Pump Inhibitor Market Challenges
13.4 Prescription Proton Pump Inhibitor Market Restraints
14 Key Findings in The Global Prescription Proton Pump Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer